Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Exact Sciences Corporation - Common Stock (NQ: EXAS )

49.31 -1.28 (-2.53%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Exact Sciences Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2023
Via Benzinga
Which Is the Better Cancer-Testing Healthcare Stock: Exact Sciences or Guardant Health?
The oncology diagnostic companies are looking for better solutions in early cancer diagnosis. 
Via The Motley Fool
2 Cathie Wood Stocks That Could Deliver Exponential Returns
These two cutting-edge healthcare companies could be significantly undervalued right now. 
Via The Motley Fool
7 Analysts Have This to Say About Exact Sciences
Via Benzinga
Where Will Exact Sciences Be in 5 Years?
The company's fight against cancer is only beginning. 
Via The Motley Fool
Prediction: These 2 Stocks Could Double by 2030
Don't underestimate these companies' potential. 
Via The Motley Fool
Where Will Exact Sciences Be in 5 Years?
The business is unprofitable, but it has been growing at an impressive rate in recent years. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023
Via Benzinga
2 Cathie Wood Stocks Up by 35% and 70% That Could Make You Richer
You aren't too late to the party. 
Via The Motley Fool
Analyst Ratings for Exact Sciences
Via Benzinga
Why Exact Sciences Stock Slumped Wednesday
The biotech's Q2 numbers were impressive overall, but Wall Street apparently wasn't satisfied. 
Via The Motley Fool
Exact Sciences (EXAS) Q2 2023 Earnings Call Transcript
EXAS earnings call for the period ending June 30, 2023. 
Via The Motley Fool
Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year
In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVID tests to American households starting next Monday. 
Via Benzinga
Exposures COVID-19
Agilent Technologies and Exact Sciences Agree to Terms of Sale for Resolution Bioscience
From Agilent Technologies Inc.
Via Business Wire
The 3 Best Cathie Wood Stocks to Buy Now: September 2023
Most of Cathie Wood's stock picks are not too impressive. Still, a few of them are worth considering. Here are the best Cathie Wood stocks. 
Via InvestorPlace
10 Reasons You May Want To Have Mainz Biomed (NASDAQ: MYNZ) On Your Radar
The WHO reports that colorectal cancer is the second most fatal cancer around the world. 
Via Benzinga
Is Cathie Wood The Next Warren Buffett? Apple, Tesla Define Their Investment Strategies
With a track record of 60-plus years of strong returns for investors, Warren Buffett, who turns 93 Wednesday, is considered one of the all-time 
Via Benzinga
Second Most Fatal Cancer In U.S. May Soon Face A Challenger: Mainz Biomed's (NASDAQ: MYNZ) Early Detection Tech
Colorectal cancer is the third most common cancer worldwide, and although the majority of colorectal cancer cases have historically occurred in individuals aged 45 and older, it is increasingly... 
Via Benzinga
Cathie Wood's Bullish Stance on Flying Cars: Ark Buys $3.9M Worth of Archer Aviation Shares
Via Benzinga
7 Very Oversold Nasdaq Stocks to Buy Right Now
The worries that have pushed the Nasdaq down sharply are overdone. Here are seven oversold Nasdaq oversold Nasdaq investment opportunities. 
Via InvestorPlace
Cathie Wood's Ark Invest Continues To Sell Shopify Shares Amid Q2 Ripples
Via Benzinga
Cathie Wood's Ark Invest Buys $16M Worth Of Shares Of Flying Taxi Company Archer Aviation — Sells Shopify Stock Worth Millions
Via Benzinga
Rising Fuel Costs Lead To Win For Energy, Cathie Wood's Biotech Play Loses Big - ETF Winners And Losers: Medium-Cap Returns
We performed a screening of medium-cap ETFs, defined as having Assets Under Management (AUM) between $2 billion and $10 billion - to determine what funds had the largest positive and negative returns... 
Via Benzinga
Topics ETFs
2 Supercharged Growth Stocks That Could Make You Richer
These two biotechs are poised for a sustained period of growth. 
Via The Motley Fool
This Analyst With 83% Accuracy Rate Sees Around 25% Upside In Amazon.com - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts
U.S. stocks closed lower on Friday, as investors digested the recent jobs data. The S&P 500 fell for a fourth consecutive session, also recording its worst week since March. The Dow fell 1.1%, while... 
Via Benzinga
Market Rally Under Pressure As Yields Soar; Amazon, ELF, Caterpillar Are Earnings Winners: Weekly Review
Amazon, ELF and CAT were earnings winners, but there were big losers too. 
Via Investor's Business Daily
Why Shares of Exact Sciences Corporation Are Down This Week
The company released second-quarter earnings that were improved, but investors were unimpressed. 
Via The Motley Fool
Exact Sciences Q2 Earnings Surpass Expectation, But Analyst Says Stock Has Limited Growth
Exact Sciences Corp (NASDAQ: EXAS) reported Q2 revenue of $622 million, an increase of 19%, and $617 million of core revenue, an increase of 24%, beating the  
Via Benzinga
Why Exact Sciences Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers WaveDancer, Inc. (NASDAQ: WAVD) shares climbed 86% to $0.5505. Tellenger, a subsidiary of Wavedancer, Inc., won a seven-year U.S. government contract. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2023
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.